000 | 01028 a2200277 4500 | ||
---|---|---|---|
005 | 20250518085058.0 | ||
008 | ####s 0 0 eng d | ||
022 | _a1948-5875 | ||
024 | 7 |
_a10.1021/acsmedchemlett.9b00572 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aSteeneck, Christoph | |
245 | 0 | 0 |
_aDiscovery of Hydroxyamidine Based Inhibitors of IDO1 for Cancer Immunotherapy with Reduced Potential for Glucuronidation. _h[electronic resource] |
260 |
_bACS medicinal chemistry letters _cFeb 2020 |
||
300 |
_a179-187 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
700 | 1 | _aKinzel, Olaf | |
700 | 1 | _aAnderhub, Simon | |
700 | 1 | _aHornberger, Martin | |
700 | 1 | _aPinto, Sheena | |
700 | 1 | _aMorschhaeuser, Barbara | |
700 | 1 | _aBraun, Floriane | |
700 | 1 | _aKleymann, Gerald | |
700 | 1 | _aHoffmann, Thomas | |
773 | 0 |
_tACS medicinal chemistry letters _gvol. 11 _gno. 2 _gp. 179-187 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1021/acsmedchemlett.9b00572 _zAvailable from publisher's website |
999 |
_c30647916 _d30647916 |